June 30 2023 at 12:01AM FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

FDA approves Roctavian, the first adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FU6lsWf